DailyIQ
|
Sector:IndustrialsAll sectors
Last updated 1 hour ago

IEX·IDEX Corporation

$.
+. (+.%)
High
$211.97
Open
$211.97
Market Cap
15.45B
52W High
$223.84
Low
$209.17
P. Close
$208.78
P/E
30.44
52W Low
$157.25
Fwd P/E
22.63
Mean Target
-
Technical Score (1D)
82
BUY
News Sentiment
53
MIXED
IDEX Corporation reported first-quarter earnings that surpassed analyst estimates, driven by strong demand in its Health & Science Technologies segment, particularly in AI-related data center power and semiconductor markets, as well as strength in space and defense. This performance led the company to raise its full-year outlook, supported by record orders and a year-over-year increase in net sales. Analysts have responded positively, with Seaport Global, Argus, and Stifel all increasing their price targets for IDEX, reflecting continued confidence in the company's prospects. Despite this recent positive momentum and analyst upgrades, some analyses suggest that IDEX's valuation score is currently low, indicating a need to look beyond traditional metrics. Older reports also highlight concerns about underperforming organic revenue growth over the past two years and lagging earnings growth compared to peers, with eroding returns on capital suggesting aging profit centers. A significant insider transaction, where a director sold over $3.3 million in shares, also provides insight into executive liquidity management. Moving forward, investors should watch for continued strength in the Health & Science Technologies segment and how the company addresses its core business performance relative to its valuation.
Earnings Summary
IDEX Corporation is a global provider of applied solutions, operating across North America, Europe, Asia, and other international markets. The company's diverse portfolio is structured into three primary segments: Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products, serving a broad spectrum of industrial needs within the Industrials sector, specifically in Specialty Industrial Machinery. In its most recent reported quarters, IDEX Corporation demonstrated a mixed performance. For Q1 2026, the company reported an actual EPS of $2.00 against an estimate of $2.08797, and revenue of $886.9 million against an estimate of $888.5 million, indicating a miss on both metrics. This followed a Q4 2025 where actual EPS was $2.10 versus an estimate of $2.0636, and actual revenue was $899.1 million against an estimate of $891.25 million, showing a beat on both. Prior to this, Q3 2025 saw actual EPS of $2.03 against an estimate of $1.9303, and Q2 2025 reported actual EPS of $2.07 against an estimate of $1.98998, both representing beats. Historically, IDEX Corporation has shown a pattern of beating analyst estimates for EPS in three of the last four reported quarters (Q2 2025, Q3 2025, Q4 2025), with revenue estimates also being met or exceeded in the most recent periods where data is available. The company's trajectory shows consistent revenue generation, though EPS performance relative to estimates has varied, with a notable miss in the latest quarter. Recent news highlights IDEX Corporation's strategic focus on high-margin customers and products through a decentralized operating model and an 80/20 framework, with the Health & Science Technologies segment benefiting from secular tailwinds in the semiconductor industry. Management participation in the Oppenheimer 21st Annual Industrial Growth Virtual Conference and a raised price target from Seaport Global to $250 from $240 with a reiterated Buy rating signal positive analyst sentiment. Moving forward, investors will be watching for the company's ability to maintain its revenue growth momentum and how the Health & Science Technologies segment continues to perform amidst industry tailwinds. Key will be the company's performance in the upcoming quarter, particularly its ability to return to beating EPS estimates following the recent miss, and how its strategic initiatives translate into financial results.

EPS

EstBeatMiss
$1.57$1.72$1.87$2.03$2.18Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.11 - -
Q1'26$2.09$2.00-4.2%
Q4'25$2.06$2.10+1.8%
Q3'25$1.93$2.03+5.2%
Q2'25$1.99$2.07+4.0%
Q1'25$1.64$1.75+6.7%

Revenue

EstBeatMiss
$799M$832M$864M$897M$930MQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$915M - -
Q1'26$889M$887M-0.2%
Q4'25$891M$899M+0.9%
Q3'25 - $879M -
Q2'25 - $865M -
Q1'25 - $814M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

IEX Stock Snapshot

IEX is currently trading at $210.25, giving IDEX Corporation a market cap of 15.45B and a P/E ratio of 30.4. Today's range spans $209.17–$211.97, with shares opening at $211.97 and moving up $1.47 (0.7%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 53/100.

Over the past year IEX has traded between $157.25 and $223.84 - the current price is +33.7% off the 52-week low and -6.1% from the high.

What IEX has right now - BUY signal, 82/100 technical score, neutral sentiment at 53/100, price $210.25 (in the upper portion of its 52-week range) - is the profile that shows up in screens looking for Industrials growth stories with technical confirmation. (P/E: 30.4) At 15.45B in capitalization, the risk/reward of a setup like this is often better than in mega-cap peers where the same signal translates to a smaller percentage move. Range: $157.25–$223.84.

The combination of a BUY signal (82/100) and neutral news sentiment (53/100) puts IEX on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 15.45B in Industrials market cap without immediately moving the stock. At $210.25 (in the upper portion of its 52-week range in the $157.25–$223.84 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…